Study highlights potential role of statin drug in critical COVID-19 cases By iopac on October 27, 2023 Simvastatin had been shown to reduce pulmonary and systemic inflammation in mouse and human models of lung injury. Published in COVID-19 iopac More from COVID-19More posts in COVID-19 »Peer support valuable intervention for health worker stress during COVID-19, study showsGlobal survey shows COVID booster uptake in questionStudy: COVID vaccines not linked to seizuresCOVID booster linked to 25% lower odds of long COVID